ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31

PMGC Holdings Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$2.83+0.06 (+2.17%)

Close on Oct 19, 2026

Market cap: $13.80M
P/E (TTM): –
Dividend yield: –

PMGC Holdings Inc. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31
Depreciation & Amortization	0.10	0.00	–	–
Stock-Based Compensation	-0.02	0.10	0.49	0.17
Deferred Income Taxes	0.03	–	–	–
Change in Accounts Receivable	-0.10	-0.01	-0.02	-0.01
Change in Inventory	0.15	-0.40	-0.27	-0.07
Change in Accounts Payable	0.96	0.21	0.47	0.07
Operating Cash Flow	-5.93	-5.49	-4.56	-1.59
Capital Expenditures	-0.44	-0.01	-0.01	–
Acquisitions	-2.16	–	–	–
Sale of Property, Plant & Equipment	–	–	–	0.00
Purchase of Investments	-1.79	-0.14	–	–
Sale & Maturity of Investments	1.76	–	–	–
Investing Cash Flow	-2.77	-0.61	-0.01	-0.03
Stock Issued	–	6.99	1.46	–
Debt Repaid	–	-1.15	–	–
Financing Cash Flow	10	6.76	6.74	2.36
Foreign Exchange Rate Adjustments	0.00	0.00	0.00	0.00
Net Change in Cash	1.42	0.66	2.17	0.74
Free Cash Flow	-6.38	-5.50	-4.57	–
Interest Paid	0.04	0.07	0.01	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 31.1%
Operating margin: –
Net margin: -523.0%
Return on equity, FY2025: -106.9%

Financial strength

Current ratio: 1.36
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 118.4%

Valuation

P/E ratio: –
Price to sales: 5.35
Price to book: 0.82
Dividend yield: –